4//SEC Filing
Baird Melissa 4
Accession 0001773751-25-000118
CIK 0001773751other
Filed
Apr 9, 8:00 PM ET
Accepted
Apr 10, 4:30 PM ET
Size
14.8 KB
Accession
0001773751-25-000118
Insider Transaction Report
Form 4
Baird Melissa
Chief Operating Officer
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2025-04-09−33,337→ 22,569 totalExercise: $1.75Exp: 2029-11-06→ Class A Common Stock (33,337 underlying) - Exercise/Conversion
Class A Common Stock
2025-04-09$1.75/sh+33,337$58,340→ 838,420 total - Sale
Class A Common Stock
2025-04-09$26.94/sh−11,735$316,094→ 816,486 total - Sale
Class A Common Stock
2025-04-09$29.23/sh−8,392$245,263→ 805,083 total - Sale
Class A Common Stock
2025-04-09$25.82/sh−10,199$263,373→ 828,221 total - Sale
Class A Common Stock
2025-04-09$28.55/sh−3,011$85,958→ 813,475 total
Footnotes (6)
- [F1]The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2024 by the Reporting Person.
- [F2]Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $25.56 - $26.355. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F3]Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $26.645 - $27.51. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F4]Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $27.805 - $28.775. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F5]Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $28.85 - $29.545. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F6]Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 250,000 shares of Hims, Inc., with an exercise price of $0.79. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 113,245 shares of the Company with an exercise price of $1.75. 100% of the shares subject to the option have vested.
Documents
Issuer
Hims & Hers Health, Inc.
CIK 0001773751
Entity typeother
Related Parties
1- filerCIK 0001837815
Filing Metadata
- Form type
- 4
- Filed
- Apr 9, 8:00 PM ET
- Accepted
- Apr 10, 4:30 PM ET
- Size
- 14.8 KB